Sarepta Therapeutics (SRPT) Gross Profit Growth (1y) (2018 - 2026)
Sarepta Therapeutics (SRPT) Gross Profit Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
75.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
7.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Sarepta Therapeutics |
1.84 Bn |
1.16 Bn |
291.52 Mn |
6,990.10% |
| Date | Value |
|---|
| Mar 31, 2026 |
6,990.10% |
| Dec 31, 2025 |
-91.59% |
| Sep 30, 2025 |
-33.80% |
| Jun 30, 2025 |
44.02% |
| Mar 31, 2025 |
-101.17% |
| Dec 31, 2024 |
25.46% |
| Sep 30, 2024 |
27.37% |
| Jun 30, 2024 |
2,781.37% |
| Mar 31, 2024 |
66.10% |
| Dec 31, 2023 |
203.04% |
| Sep 30, 2023 |
75.66% |
| Jun 30, 2023 |
-106.85% |
| Mar 31, 2023 |
2,414.93% |
| Dec 31, 2022 |
72.48% |
| Sep 30, 2022 |
1.12% |
| Jun 30, 2022 |
41.76% |
| Mar 31, 2022 |
-107.58% |
| Dec 31, 2021 |
89,045.56% |
| Sep 30, 2021 |
2,118.74% |
| Jun 30, 2021 |
864.85% |
